Insider trading

Period: 120 months Stock: EL Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

150 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

150 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

150 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

150 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
150 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
150 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

150 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Aug 2026
La Lande Rashida Exec VP & General Counsel
Sold at will
$802.38K 7,766 at 103.32
100%
Sold half or more
21 Aug 2026
La Lande Rashida Exec VP & General Counsel
Sold at will
$553.90K 5,564 at 99.55
100%
Sold half or more
26 Nov 2025
La Lande Rashida Exec VP & General Counsel
Sold at will
$151.50K 1,604 at 94.45
100%
Sold half or more
18 Nov 2025
Webster Meridith Exec VP GlobalComm/PubAffairs
Sold at will
$476.97K 5,430 at 87.84
100%
Sold half or more
28 Aug 2025
La Lande Rashida Executive VP & General Counsel
Sold at will
$589.59K 6,417 at 91.88
100%
Sold half or more
30 May 2024
LAUDER JANE Executive Vice President & CDO
Sold at will
$1.82M 14,976 at 121.26
20.7%
Not planned
22 May 2024
JUEPTNER PETER Group President
Sold at will
$1.67M 12,786 at 130.62
69.6%
Sold half or more
7 Feb 2024
Stanley Deirdre EVP & General Counsel
Sold at will
$638.42K 4,343 at 147.00
25.0%
Not planned
23 Aug 2023
LAUDER JANE Executive Vice President & CDO
Sold at will
$1.93M 12,661 at 152.75
18.5%
Not planned
16 May 2023
Hertzmark Hudis Jane Executive Group President
Sold at will 4×
$1.97M 9,869 at 199.95
46.4%
Not planned
11 May 2023
Hertzmark Hudis Jane Executive Group President
Sold at will 3×
$8.75M 43,311 at 202.09
67.1%
Sold half or more
13 Feb 2023
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$2.47M 9,741 at 253.90
67.1%
Sold half or more
9 Sep 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated 2×
$1.91M 7,559 at 252.05
69.6%
Sold half or more
7 Sep 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$613.65K 2,481 at 247.34
42.9%
7 Sep 2022
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$523.32K 2,118 at 247.08
100%
Sold half or more
25 Aug 2022
Hertzmark Hudis Jane Executive Group President
Sold, plan not stated 2×
$1.83M 6,667 at 274.30
21.4%
3 Jun 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$144.61K 548 at 263.88
14.3%
27 May 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$170.13K 671 at 253.55
14.9%
26 May 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$467.51K 1,965 at 237.92
30.3%
11 May 2022
Hertzmark Hudis Jane Executive Group President
Sold, plan not stated
$1.90M 8,256 at 230.69
21.0%
4 May 2022
LAUDER JANE EVP, Enterprise Mkg & CDataO
Sold, plan not stated 5×
$4.91M 20,032 at 245.34
27.2%
15 Feb 2022
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$354.75K 1,152 at 307.94
15.1%
10 Feb 2022
LAUDER RONALD S Chairman, Clinique Labs, LLC
Sold, plan not stated
$214.96M 700,000 at 307.08
100%
Sold half or more
9 Feb 2022
Demsey John Group President
Sold, plan not stated
$3.21M 10,027 at 319.68
60.3%
Sold half or more
4 Feb 2022
Demsey John Group President
Sold, plan not stated 7×
$7.30M 23,248 at 314.10
77.9%
Sold half or more
4 Feb 2022
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$5.08M 16,389 at 309.88
100%
Sold half or more
2 Dec 2021
Lauder William P Executive Chairman
Sold, plan not stated 5×
$13.20M 40,141 at 328.94
100%
Sold half or more
1 Dec 2021
Lauder William P Executive Chairman
Sold, plan not stated 4×
$6.13M 18,579 at 329.70
82.3%
Sold half or more
5 Nov 2021
MOSS SARA E Vice Chairman
Sold, plan not stated
$703.91K 2,035 at 345.90
100%
Sold half or more
4 Nov 2021
Hertzmark Hudis Jane Executive Group President
Sold, plan not stated
$3.08M 9,043 at 340.06
18.7%
4 Nov 2021
Haney Carl P. EVP Research Prod & Innovation
Sold, plan not stated
$569.88K 1,682 at 338.81
18.1%
3 Nov 2021
Demsey John Group President
Sold, plan not stated
$2.01M 6,000 at 335.00
47.6%
3 Nov 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$656.94K 1,961 at 335.00
100%
Sold half or more
3 Nov 2021
Haney Carl P. EVP-Global R&D
Sold, plan not stated
$504.99K 1,500 at 336.66
13.9%
3 Sep 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$1.01M 2,947 at 343.18
100%
Sold half or more
2 Sep 2021
MOSS SARA E Vice Chairman
Sold, plan not stated 2×
$1.18M 3,451 at 342.56
100%
Sold half or more
20 Aug 2021
Demsey John Group President
Sold, plan not stated 2×
$2.13M 6,500 at 327.53
76.3%
Sold half or more
7 May 2021
Demsey John Group President
Sold, plan not stated
$449.85K 1,500 at 299.90
15.0%
5 May 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated
$496.40M 1,700,000 at 292.00
100%
Sold half or more
4 May 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated 2×
$643.10K 2,183 at 294.59
100%
Sold half or more
4 May 2021
Demsey John Group President
Sold, plan not stated
$296.02K 1,000 at 296.02
9.1%
9 Apr 2021
MOSS SARA E Vice Chairman
Sold, plan not stated
$3.60M 12,000 at 300.00
100%
Sold half or more
3 Mar 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated 5×
$82.17M 281,629 at 291.76
78.2%
Sold half or more
2 Mar 2021
LAUDER RONALD S Chairman, Clinique Labs LLC
Sold, plan not stated 3×
$22.77M 78,371 at 290.52
100%
Sold half or more
1 Mar 2021
PROUVE CEDRIC Group President, International
Sold, plan not stated 4×
$4.33M 14,753 at 293.81
5.8%
25 Feb 2021
MOSS SARA E Exec. VP, Gen. Counsel
Sold, plan not stated 2×
$5.11M 17,576 at 290.78
100%
Sold half or more
25 Feb 2021
PROUVE CEDRIC Group President, International
Sold, plan not stated 3×
$1.45M 4,967 at 292.29
2.0%
24 Feb 2021
Demsey John Group President
Sold, plan not stated 9×
$13.52M 45,895 at 294.65
80.6%
Sold half or more
24 Feb 2021
PROUVE CEDRIC Group President, International
Sold, plan not stated 3×
$6.64M 22,439 at 296.05
8.6%
24 Feb 2021
O'HARE MICHAEL EVP-Global Human Resources
Sold, plan not stated
$5.61M 19,457 at 288.57
89.9%
Sold half or more
Showing 1–50 of 150. Page 1 of 3 Older →